Author: chc

FDA Mobile App Guidance Focuses on Risk, Calls for “Enforcement Discretion”

MIWG Asks FDA to Clarify Position Regarding Manufacturer Dissemination of New Use Information

Pitts Reminds Companies They Need To Be Careful With Sponsored Tweets

FDA States Keywords Do Not Have To Be Reported on Form 2253s

DMA Says FTC Commissioner’s Call for Legislation To Restrict Data Mining “Is Unfounded”

ISMPP Offers Guidance on Value of Publication Support in Sunshine Act “Suggestions Document”

PhRMA: Engaging the Consumer Is Key to Healthcare Success

OPDP: There Are “A Number of Things” Companies Can Do to Avoid Enforcement Actions

Pitts: FDA Needs to Address Guidance on Healthcare Economic Information